All In MedTech

Device Trial Radar · NCT02649946

Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft

A Prospective, Multi-Center, Randomized, Concurrently-Controlled Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in the Treatment of Stenosis in the Venous Outflow of AV Fistula Access Circuits (AVeNEW)

Last checked: Nov 20, 2026Latest source record: Dec 21, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 280 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

280

Actual

Start

Jun 2016

Primary completion

Aug 2018

Study completion Feb 2021

Sponsor

Lead sponsor
C. R. BardPublic (BDX)
Sponsor type
Industry
First posted
Jan 8, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to assess the safety and effectiveness of the COVERA™ Vascular Covered Stent for the treatment of stenotic lesions in the upper extremity venous outflow of the Arteriovenous (AV) access circuit.

Conditions

  • Stenosis
  • Restenosis

Interventions

  • Covera Vascular Covered Stent following PTADevice

    Treatment of stenoses with primary percutaneous transluminal angioplasty (PTA) and placement of the Covera Vascular Covered Stent.

  • Percutaneous Transluminal Angioplasty (PTA) with Uncoated PTA BalloonProcedure

    Treatment of stenoses with PTA only

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Effectiveness Endpoint: Number of Participants With Target Lesion Primary Patency (TLPP)Time frame: 6 months post index procedure
  2. Number of Participants With Freedom From AV Access Circuit Localized or Systemic Serious Adverse EventsTime frame: 30 days post index procedure

Locations

24 sites in 8 countries. Site status is shown where the registry gives one.

  • Southwest Vascular Center

    Tempe, Arizona

  • Alliance Research Centers

    Laguna Hills, California

  • Radiology Imaging Associates

    Englewood, Colorado

21 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.